16894343

Source:http://linkedlifedata.com/resource/pubmed/id/16894343

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021469, umls-concept:C0027686, umls-concept:C0072980, umls-concept:C0205263, umls-concept:C0221198, umls-concept:C0596290, umls-concept:C0684321
pubmed:issue	2
pubmed:dateCreated	2006-9-11
pubmed:abstractText	Rapamycin is a widely used drug with antifungal, immunosuppressant and antiangiogenic effects. Herein, we studied whether immunosuppressive doses of rapamycin are capable of influencing endometriotic lesions.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-10027628, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-10742145, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-10935468, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11057898, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11331305, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11696427, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11821896, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11867907, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-11874702, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-15457566, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-15501979, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-15671443, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-15859902, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-16172144, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-16210012, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-4821168, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-561019, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-6501094, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-8274192, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-9109485, http://linkedlifedata.com/resource/pubmed/commentcorrection/16894343-9552353
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502536
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0007-1188
pubmed:author	pubmed-author:ElitzschAA, pubmed-author:HolsteinJ HJH, pubmed-author:LaschkeM WMW, pubmed-author:MengerM DMD, pubmed-author:ScheuerCC, pubmed-author:VollmarBB
pubmed:copyrightInfo	Published online 7 August 2006.
pubmed:issnType	Print
pubmed:volume	149
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	137-44
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:16894343-Animals, pubmed-meshheading:16894343-Aorta, pubmed-meshheading:16894343-Cell Proliferation, pubmed-meshheading:16894343-Cricetinae, pubmed-meshheading:16894343-Endometriosis, pubmed-meshheading:16894343-Female, pubmed-meshheading:16894343-Immunosuppressive Agents, pubmed-meshheading:16894343-Mesocricetus, pubmed-meshheading:16894343-Microscopy, Fluorescence, pubmed-meshheading:16894343-Neovascularization, Pathologic, pubmed-meshheading:16894343-Sirolimus
pubmed:year	2006
pubmed:articleTitle	Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.
pubmed:affiliation	Institute for Clinical and Experimental Surgery, University of Saarland, Homburg/Saar, Germany. matthias.laschke@uniklinik-saarland.de
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't